Press Releases

Press Releases

Date	Title	Format
July 12, 2021	Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021	PDF Version
July 7, 2021	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
June 9, 2021	Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer and Andrew King, D.V.M, Ph.D., to Chief Scientific Officer	PDF Version
June 8, 2021	Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress	PDF Version
May 25, 2021	Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress	PDF Version
May 13, 2021	Chinook Therapeutics to Present at the 2021 RBC Capital Markets Global Healthcare Conference	PDF Version
May 12, 2021	Chinook Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results	PDF Version
May 4, 2021	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
April 15, 2021	Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021	PDF Version
April 8, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version

Email Alerts

Investors